Close

Articles

Data-Driven Planning for the Participant Burden in Clinical Trials

Current State of the Participant Experience Participating in a clinical trial requires a commitment of one’s time and effort. This is inclusive of trial-related expenses, logistical requirements and more – but a key reason there is such burden associated with...

Powering Through Into 2025 With A Strong Foundation

World Pharma Today, in its advent to be the standalone ready-reckoner in the pharma domain, is proud to present expert predictions for 2025 from leading voices in the pharmaceutical industry. From groundbreaking advancements in bioconjugates and cell and gene...

Maximizing clinical drug development success through an innovative outsourcing model

In an industry marked by increasing complexity and high stakes, the shift toward a single, comprehensive outsourcing partner for both contract development and manufacturing organization (CDMO) and contract research organization (CRO) services offers biotech and pharma companies a transformative...

Production of incretin mimetics: weight under control

Losing weight at the touch of a button: although this might sound too simple to be true, extensive pharmaceutical development has made it a reality for patients with type 2 diabetes and obesity. Incretin mimetics administered by auto-injectors or pens...

Achieve Safety Culture Excellence with Digital Control of Work

Pharmaceutical and Biopharmaceutical* manufacturing is not only at the forefront of global health but also a key driver of economic growth, with the sector valued at over $1.5 trillion worldwide. Every day, millions of pharma manufacturing workers across the...

Accelerating Access to Life-Changing Therapies: The Role of Pharma Packaging

In the last decade, Cell and Gene therapies (CGTs) have emerged as a popular treatment option for complex diseases. Some of the factors contributing to this rapid growth include technological advancements in manufacturing techniques, vector design, and delivery systems...

The importance of GMP in ensuring the Quality and Safety of Complex Therapeutics

Good Manufacturing Practices (GMPs) are foundational in ensuring Quality and Safety in the biopharmaceutical industry. As therapeutics become ever more complex and as a consequence regulatory scrutiny increases, understanding how to apply GMPs is more critical than ever. At...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read